Friday, September 25, 2020
Home Life Style Health & Fitness Novel Treatment Offers Promise to Stop Parkinson's

Novel Treatment Offers Promise to Stop Parkinson’s

After nine months, there was no change in the PET scans of those who received placebo. On the other hand, the group who received GDNF showed an improvement of 100 per cent in a key area of the brain affected in the condition

An experimental treatment that delivers a drug directly to the brain has shown promise for slowing, stopping, or even reversing Parkinson’s disease, say researchers.

The study, by a team led by University of Bristol researchers, in a clinical trial investigated whether the treatment called Glial Cell Line Derived Neurotrophic Factor (GDNF) — a natural protein, found in the brain — can regenerate dying dopamine brain cells in patients with Parkinson’s and reverse their condition, something no existing treatment can do.

The results potentially demonstrated that the new treatment was starting to reawaken and restore damaged brain cells and that repeated brain infusion is clinically feasible and tolerable, according in the Journal of Parkinson’s Disease.

The study “represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells that are gradually destroyed in Parkinson’s”, said principal investigator Alan L. Whone, from the University of Bristol in the UK.

After an initial safety study of six people, 35 individuals were enrolled in the nine-month double blind trial, in which half were randomly assigned to receive monthly infusions of GDNF and the other half placebo infusions.

Parkinson's Disease
Parkinson’s Disease Gets Awareness From Various Events. Flickr

All participants underwent robot-assisted surgery to have four tubes placed into their brains, which allowed GDNF or placebo to be infused directly to the affected areas with pinpoint accuracy, via a port in their head.

After implantation the team administered, more than 1,000 brain infusions, once every four weeks.

After nine months, there was no change in the PET scans of those who received placebo. On the other hand, the group who received GDNF showed an improvement of 100 per cent in a key area of the brain affected in the condition.

Also Read- Now Machine Learning Can Help in Predicting Earthquakes

“This trial has shown that we can safely and repeatedly infuse drugs directly into patients’ brains over months or years,” said Steven Gill, lead neurosurgeon at North Bristol NHS Trust, Bristol, UK

“This is a significant breakthrough in our ability to treat neurological conditions, such as Parkinson’s, because most drugs that might work cannot cross from the blood stream into the brain due to a natural protective barrier.” (IANS)

STAY CONNECTED

19,140FansLike
362FollowersFollow
1,776FollowersFollow

Most Popular

People Avoid Masks Due to Breathing Problems: Study

When it came to non-compliance towards covering the face, breathing problems have emerged as a key reason, with 50 percent listing it in a...

Women More Vulnerable to Uncurbed Diabetes

Traditionally, women play the role of caregivers in India when it comes to families and their health. They prioritize the health of their loved...

Australia Rescuing Helpless Beached Whales

Rescuers of Australia are trying to save scores of beached whales on the shore in the state of Tasmania. Earlier this week, a pod...

Hydroponic Farm Method Making its way in India

The rows of lettuce, microgreens, and herbs that Himanshu Aggarwal and his mother grow in an enclosed room in a busy New Delhi market...

Walmart Aims for Zero Global Emissions by 2040 

U.S.-based retail giant Walmart has unveiled new initiatives to reduce its global carbon footprint while preserving the world’s natural land and sea habitats. The company...

NASA Unveils Plan to Land First Woman on the Moon in 2024

The U.S. National Aeronautics and Space Administration (NASA) has unveiled a plan to land the first woman on the moon in 2024. NASA Administrator Jim...

42% of Indian Workers Use Personal Devices to Access Corporate Data

As the lines between work and home life get increasingly blurred, 42 per cent of workers in India are using personal devices to access...

Karan Kundra: Drugs are the Choice of an Individual, Not of an Industry

BY ARUNDHUTI BANERJEE Popular television actors Karan Kundra and Yogita Bihani feel the constant negative narratives that are lately doing the rounds about the entertainment...

Recent Comments